Skip to content

KORU Medical Systems KRMD Return on equity

Return on equity at other companies

Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.6%-1.3pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-612.1%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
13.9%+8.0pp
UFP Technologies logo
UFP TechnologiesUFPT
17.2%-2.2pp
ICU Medical logo
ICU MedicalICUI
-0.4%-0.2pp

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Calculated from KORU Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's return on equity?
KORU Medical Systems (KRMD) reported return on equity of -13.7% in Q1 2026.
How has KORU Medical Systems's return on equity changed year-over-year?
KORU Medical Systems's return on equity increased by 54.1% year-over-year, from -29.9% to -13.7%.
What is the long-term trend for KORU Medical Systems's return on equity?
Over 5 years (2020 to 2025), KORU Medical Systems's return on equity has grown at a 25.0% compound annual growth rate (CAGR), from -5.1% to -15.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.